Eli Lilly and Company (0Q1G.L)
LSE - LSE Delayed price. Currency in CHF
Add to watchlist
At close: 03:18PM GMT
| Previous close | 244.96 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 4,996 |
| Market cap | 4.911B |
| Beta (5Y monthly) | 0.33 |
| PE ratio (TTM) | 0.83 |
| EPS (TTM) | 6.52 |
| Earnings date | 06 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksEli Lilly (LLY) Rises Higher Than Market: Key Facts
The latest trading day saw Eli Lilly (LLY) settling at $598.05, representing a +1.66% change from its previous close.
PR NewswireLilly Announces 15% Dividend Increase, First-Quarter 2024 Dividend
The board of directors of Eli Lilly and Company (NYSE: LLY) has announced a 15% increase in its quarterly dividend and declared a dividend for the first quarter of 2024 of $1.30 per share on outstanding common stock.
ZacksPharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
AbbVie (ABBV) offers to acquire Cerevel Therapeutics for $8.7 billion. J&J (JNJ) announces sales and earnings growth expectations for 2024.
© 2023 Yahoo. All rights reserved.